SeaStar Medical Holding Corporation Share Price
ICUSeaStar Medical Holding Corporation Stock Performance
Open $0.48 | Prev. Close $0.48 | Circuit Range N/A |
Day Range $0.48 - $0.48 | Year Range $0.30 - $3.07 | Volume 149 |
Average Traded $0.48 |
SeaStar Medical Holding Corporation Share Price Chart
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $0.48 | $0.48 | +0.00% |
12-Nov-25 | $0.48 | $0.48 | -1.44% |
11-Nov-25 | $0.49 | $0.49 | +1.89% |
10-Nov-25 | $0.49 | $0.48 | -1.45% |
07-Nov-25 | $0.45 | $0.48 | +4.99% |
06-Nov-25 | $0.49 | $0.46 | -8.71% |
05-Nov-25 | $0.44 | $0.51 | +2.64% |